2013
DOI: 10.1245/s10434-013-3129-9
|View full text |Cite
|
Sign up to set email alerts
|

Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial

Abstract: NAC-GS was well tolerated and safe when used in a multi-institutional setting. The R0 resection rate and the 2-year survival rate analysis are encouraging for patients with resectable and borderline PDAC.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
88
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 138 publications
(95 citation statements)
references
References 37 publications
6
88
0
1
Order By: Relevance
“…27,28 Increasing numbers of patients will probably receive preoperative chemotherapy in the future. Therefore, methods that effectively prevent obstruction in the long term are needed.…”
Section: Discussionmentioning
confidence: 99%
“…27,28 Increasing numbers of patients will probably receive preoperative chemotherapy in the future. Therefore, methods that effectively prevent obstruction in the long term are needed.…”
Section: Discussionmentioning
confidence: 99%
“…More recently, regimens such as FOLFIRINOX [7] and albumin-bound paclitaxel plus gemcitabine [8] represent a 'new era' of treatment for PDA patients. These new options improve survival, and serve as neoadjuvant chemotherapy for locally advanced and borderline resectable disease [9,10,11]. The identification of rational therapeutic strategies based on the diversity of the molecular signature is therefore warranted.…”
Section: Introductionmentioning
confidence: 99%
“…Although BRPC may technically be resectable, it has a particularly high risk of margin-positive resection and postoperative recurrence. Furthermore, the prognosis is much worse than that of resectable pancreatic cancer [16,17]. Therefore, recognition of BRPC is important for optimal patient care and evaluation of various new treatment strategies.…”
Section: Introductionmentioning
confidence: 99%